- Location
2
results for "
Insomnia Drug
"-
Purdue Pharma Has Announced The Availability of Intermezzo Sublingual Tablet CIV
Nov 28, 2012Purdue Pharma has announced the availability of Intermezzo sublingual tablet CIV in 1.75mg and 3.5mg dosage strengths for insomnia characterized by middle-of-the-night awakenings followed by difficulty returning to sleep. ...
Tags: Purdue Pharma, Insomnia Drug, Intermezzo sublingual tablet CIV
-
Eisai Has Introduced The Insomnia Drug, Lunesta in Japan
Nov 28, 2012Eisai has introduced the insomnia drug, Lunesta (eszopiclone), in Japan. Discovered and developed by Sunovion Pharmaceuticals, Lunesta is a non-benzodiazepine type GABAA agonist (non-benzodiazepine sedative hypnotic). In a Phase II/III ...
